The Plasma Proteins Market in Canada — 2017/2018
The report on The Plasma Proteins Market in Canada – 2017/18 updates the same title published every two years. Two non-profit organizations (Canadian Blood Services and Héma-Québec) distribute most plasma and recombinant products, which distinguishes the market from other countries’. The effects of recent regulatory measures and on-going, economic and health care issues are examined in this report, which also provides sales data of all the major plasma-derived and recombinant proteins.
The report is delivered electronically (Excel and/or pdf files) and a hard copy is available. For more information or to order this report, please contact The Marketing Research Bureau at mrb_ibpn@earthlink.net, or +1 203 799-0298.
THE PLASMA PROTEINS MARKET IN CANADA — 2017/2018
TABLE OF CONTENTS
EXECUTIVE SUMMARY
HEALTH CARE ENVIRONMENT
BLOOD AND PLASMA COLLECTIONS
Historical Development
Blood Safety
Whole Blood Collections
Project Recovery
Remunerated Plasma Collection Controversy and Resolution
Canadian Blood Services (CBS)
Historical Development
Production and Distribution of Blood Components and Plasma Products
Héma-Québec (HQ)
Historical Development
Production and Distribution of Blood Components and Plasma Products
PLASMA FRACTIONATION
Historical Development
Contracts for Fractionation, Plasma-products and
Recombinant FVIII and FIX
Emergent BioSolutions (formerly Cangene Corporation)
Prometic Life Sciences
Therapure Biopharma
Green Cross Fractionation Plant
MARKET OVERVIEW
INTRAMUSCULAR IMMUNE GLOBULIN
Polyvalent Intramuscular Immune Globulin (IMIG)
Rho(D) Immune Globulin
Rabies Immune Globulin
Hepatitis A Immune Globulin
Hepatitis B Immune Globulin
Varicella Zoster Immune Globulin
Cytomegalovirus Hyperimmune Globulin
POLYVALENT INTRAVENOUS & SUBCUTANEOUS
IMMUNE GLOBULIN (IVIG & SCIG)
Intravenous Polyvalent Immune Globulin (IVIG)
Subcutaneous Polyvalent Immune Globulin (SCIG)
IgG Usage by Indication in Canada
Efforts to control IgG Usage
ALBUMIN MARKET
HEMOPHILIA CARE AND COAGULATION MARKET
Patient Population
Hemophilia Treatment
Factor VIII Market
Factor IX Market
Von Willebrand Disease Market
Inhibitors Market (APCC & rFVIIa)
Prevalence
Market Development
Prothrombin Complex Concentrate Market (PCC)
Other Bleeding Disorders
Factor VII
Factor XI
Factor XIII
Fibrinogen
OTHER PLASMA PRODUCTS
Alpha 1 Protease Inhibitor (A1PI)
C1 Esterase Inhibitor (C1-INH)
Antithrombin III
Protein C
Fibrin Sealant
Solvent Detergent-Treated Plasma (S/D Plasma)
PRICING AND DISTRIBUTION
MARKET TRENDS AND THREE-YEAR FORECAST
LIST OF MAJOR COMPANIES AND ORGANIZATIONS